LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.43 | 84.90 | 1630 | 3459 | 0.4712 | 0.7375 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.43 | 84.90 | 73 | 3459 | 0.0211 | -0.0278 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.43 | 84.90 | 1654 | 3459 | 0.4781 | 0.7423 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 40.14 | 84.90 | 1656 | 3682 | 0.4498 | 0.7267 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 40.14 | 84.90 | 1674 | 3682 | 0.4546 | 0.7302 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 40.14 | 84.90 | 85 | 3682 | 0.0231 | 0.0002 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 40.14 | 84.90 | 1840 | 3682 | 0.4997 | 0.7605 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.84 | 84.90 | 1786 | 4003 | 0.4462 | 0.7297 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.84 | 84.90 | 1802 | 4003 | 0.4502 | 0.7325 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.84 | 84.90 | 93 | 4003 | 0.0232 | 0.0165 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.84 | 84.90 | 1845 | 4003 | 0.4609 | 0.7399 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.55 | 84.90 | 1876 | 4287 | 0.4375 | 0.7282 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.55 | 84.90 | 1919 | 4287 | 0.4475 | 0.7351 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.55 | 84.90 | 109 | 4287 | 0.0254 | 0.0452 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.55 | 84.90 | 2126 | 4287 | 0.4958 | 0.7668 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.25 | 84.90 | 2024 | 4539 | 0.4458 | 0.7375 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.25 | 84.90 | 2041 | 4539 | 0.4496 | 0.7400 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.25 | 84.90 | 118 | 4539 | 0.0260 | 0.0590 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.25 | 84.90 | 2303 | 4539 | 0.5073 | 0.7770 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.95 | 84.90 | 2158 | 4952 | 0.4357 | 0.7359 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.95 | 84.90 | 2179 | 4952 | 0.4400 | 0.7388 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.95 | 84.90 | 174 | 4952 | 0.0351 | 0.1301 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.95 | 84.90 | 2479 | 4952 | 0.5006 | 0.7775 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 48.65 | 84.90 | 2271 | 5328 | 0.4262 | 0.7338 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 48.65 | 84.90 | 2294 | 5328 | 0.4305 | 0.7368 | MN20160318_Q02 | C03 |